immune system
N |
• mice are able to clear infections of Pneumocystis carinii, similar to controls
|
• splenocytes from BCG infected mice exhibit increased proliferation in response to Con A
|
• significantly lower resting splenic NK cell activity
(J:66802)
• recruitment of NK cells to the liver by recombinant murine IL12 is impaired
(J:115033)
• however, the recruitment of T cells by IL12 is not impaired
(J:115033)
|
• macrophages from BCG infected mice fail to produce nitric oxide in response to LPS challenge
• macrophages from BCG infected mice exhibit reduced production of superoxide anion in response to PMA challenge
|
• macrophages from BCG infected mice exhibit reduced class II expression
|
• exposure to UVA and UVB fails to significantly reduce the UVB induced suppression of the type IV hypersensitivity reaction
• however, the type IV hypersensitivity reaction in the absence of UV exposure is similar to controls
|
• increased mortality following a sublethal dose of Mycobacterium bovis (BCG )
|
• mice infected with Plasmodium berghei ANKA are protected from development of experimental cerebral malaria and survive longer than wild-type mice
• however, IFNG-competent alpha+CD4+ T cells promote experimental cerebral malaria
|
• mice infected with Plasmodium berghei ANKA are protected from development of experimental cerebral malaria and survive longer than wild-type mice
|
• reduced surival of cardiac grafts relative to controls
|
growth/size/body
• modest increase in alveolar bone loss at 30 weeks relative to mice at 6 and 16 weeks
|
neoplasm
• following treatment with alphaGalCer, mice fail to exhibit a reduction in the number of B16F10 tumors metastasizing to the lungs unlike similarly treated wild-type mice
|
• tumor-bearing mice treated with Th-17-polarized cells from Tg(Tcra,Tcrb)9Rest cells show increased tumor rejection compared to controls
|
craniofacial
• modest increase in alveolar bone loss at 30 weeks relative to mice at 6 and 16 weeks
|
skeleton
• modest increase in alveolar bone loss at 30 weeks relative to mice at 6 and 16 weeks
|
hematopoietic system
• splenocytes from BCG infected mice exhibit increased proliferation in response to Con A
|
• significantly lower resting splenic NK cell activity
(J:66802)
• recruitment of NK cells to the liver by recombinant murine IL12 is impaired
(J:115033)
• however, the recruitment of T cells by IL12 is not impaired
(J:115033)
|
• macrophages from BCG infected mice fail to produce nitric oxide in response to LPS challenge
• macrophages from BCG infected mice exhibit reduced production of superoxide anion in response to PMA challenge
|
• macrophages from BCG infected mice exhibit reduced class II expression
|
integument
• following exposure to UVA and UVB mice fail to develop significant erythema unlike wild-type controls
• however, the increase in skin fold thickness in response to UVB or UVA and UVB exposure is not significantly different from controls
|
cellular
• splenocytes from BCG infected mice exhibit increased proliferation in response to Con A
|
mortality/aging
• mice infected with Plasmodium berghei ANKA are protected from development of experimental cerebral malaria and survive longer than wild-type mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
malaria | DOID:12365 | J:189794 |